JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, R N
Right arrow Articles by Gavan, T L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, R N
Right arrow Articles by Gavan, T L

 Previous Article  |  Next Article 

J Clin Microbiol. 1981 January; 13(1): 184-194

Evaluation of the Sceptor microdilution antibiotic susceptibility testing system: a collaborative investigation.

R N Jones, C Thornsberry, A L Barry and T L Gavan

ABSTRACT

A multiwell, dried antimicrobial agent susceptibility test system, Sceptor (BBL Microbiology Systems, Cockeysville, Md.), was tested. The system was compared directly with a reference microdilution method by using two collections of stock cultures and 305 fresh clinical isolates. Sceptor was found to be in agreement (+/- log2 dilution) with the reference microdilution method in 96.9 to 98.3% of 9,840 minimal inhibitory concentration determinations performed on stock strains and 95.0% of 7,308 minimal inhibitory concentrations obtained from the clinical isolates. The intralaboratory and interlaboratory reproducibility on stock strains was 97.6 and 97.2%, respectively. The intralaboratory reproducibility for the clinical isolates was 96.9%. Sceptor accurately categorized representative challenge strains of methicillin-resistant staphylococci, beta-lactamase-producing bacteria, organisms producing other antimicrobial agent-inactivating enzymes, and permeability mutants as resistant. Only 0.2% very major errors (false-sensitive minimal inhibitory concentrations by Sceptor) were identified among the clinical isolate test results, the majority being clinically insignificant. The product is accurate and reliable, has a long shelf life, and seems applicable for routine use in clinical laboratories.


J Clin Microbiol. 1981 January; 13(1): 184-194







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1981 by the American Society for Microbiology. All rights reserved.